Filing Details
- Accession Number:
- 0001209191-23-052108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-04 18:43:29
- Reporting Period:
- 2023-10-03
- Accepted Time:
- 2023-10-04 18:43:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1231457 | Genelux Corp | GNLX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1937513 | Aladar Szalay | C/O Genelux Corporation, 2625 Townsgate Road, Suite 230 Westlake Village CA 91361 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2023-10-03 | 75,690 | $25.49 | 1,441,487 | No | 4 | S | Indirect | By Trust |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By Trust |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,000 | Indirect | By Spouse |
Common Stock | 2,258,760 | Indirect | By Trust |
Common Stock | 550,000 | Indirect | By Trust |
Footnotes
- The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $25.285 to $25.75, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- Shares held by The Szalay 2010 Retained Annuity Trust.
- Shares held by The Szalay 2009 Irrevocable Trust.
- Shares held by The Szalay 2010 Children's Trust.